Endocrine Effects of Anorexia Nervosa

Endocrinology and Metabolism Clinics of North America

Volumn 42, Issue 3, 2013, Pages 515-528

  Miller, Karen Klahr ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Anorexia nervosa; Growth hormone; Hypercortisolemia; Hypogonadism; Osteoporosis

Indexed keywords

GHRELIN; GROWTH HORMONE; LEPTIN; PEPTIDE YY; RECOMBINANT SOMATOMEDIN C; RISEDRONIC ACID; SOMATOMEDIN C;

ANOREXIA NERVOSA; BONE ATROPHY; CAUSAL ATTRIBUTION; HORMONE RESISTANCE; HUMAN; HYPERCORTISOLISM; HYPOGONADISM; HYPOTHALAMIC AMENORRHEA; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; REVIEW;

ANOREXIA NERVOSA; GROWTH HORMONE; HYPERCORTISOLEMIA; HYPOGONADISM; OSTEOPOROSIS;

ANOREXIA NERVOSA; APPETITE; ENDOCRINE SYSTEM DISEASES; FEMALE; HUMAN GROWTH HORMONE; HUMANS; MALE;

EID: 84883509441     PISSN: 08898529     EISSN: 15584410     Source Type: Journal    
DOI: 10.1016/j.ecl.2013.05.007     Document Type: Review

References (80)

1. Gull WW. Address in medicine delivered before the Annual Meeting of the British Medical Association at Oxford. Lancet 1868;2:171-6.
2. Eddy K.T., Keel P.K., Dorer D.J., et al. Longitudinal comparison of anorexia nervosa subtypes. Int J Eat Disord 2002, 31(2):191-201.
3. Lucas A.R., Beard C.M., O'Fallon W.M., et al. 50-year trends in the incidence of anorexia nervosa in Rochester, Minn.: a population-based study. Am J Psychiatry 1991, 148(7):917-922.
4. Garfinkel P.E., Lin E., Goering P., et al. Should amenorrhoea be necessary for the diagnosis of anorexia nervosa? Evidence from a Canadian community sample. Br J Psychiatry 1996, 168(4):500-506.
5. Hoek H.W., van Hoeken D. Review of the prevalence and incidence of eating disorders. Int J Eat Disord 2003, 34(4):383-396.
6. Walters E.E., Kendler K.S. Anorexia nervosa and anorexic-like syndromes in a population-based female twin sample. Am J Psychiatry 1995, 152(1):64-71.
7. Fairburn C.G., Harrison P.J. Eating disorders. Lancet 2003, 361(9355):407-416.
8. Huas C., Caille A., Godart N., et al. Factors predictive of ten-year mortality in severe anorexia nervosa patients. Acta Psychiatr Scand 2011, 123(1):62-70.
9. Keel P.K., Dorer D.J., Eddy K.T., et al. Predictors of mortality in eating disorders. Arch Gen Psychiatry 2003, 60(2):179-183.
10. Miller K.K., Grinspoon S.K., Ciampa J., et al. Medical findings in outpatients with anorexia nervosa. Arch Intern Med 2005, 165(5):561-566.
11. Boyar R.M., Hellman L.D., Roffwarg H., et al. Cortisol secretion and metabolism in anorexia nervosa. NEngl J Med 1977, 296(4):190-193.
12. Sabel A.L., Gaudiani J.L., Statland B., et al. Hematological abnormalities in severe anorexia nervosa. Ann Hematol 2013, 92(5):605-613.
13. Frisch R.E., McArthur J.W. Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance or onset. Science 1974, 185(4155):949-951.
14. Boyar R.M., Katz J., Finkelstein J.W., et al. Anorexia nervosa. Immaturity of the 24-hour luteinizing hormone secretory pattern. NEngl J Med 1974, 291(17):861-865.
15. Katz J.L., Boyar R., Roffwarg H., et al. Weight and circadian luteinizing hormone secretory pattern in anorexia nervosa. Psychosom Med 1978, 40(7):549-567.
16. Jocoangeli F., Masala S., Staar Mezzasalma F., et al. Amenorrhea after weight recovery in anorexia nervosa: role of body composition and endocrine abnormalities. Eat Weight Disord 2006, 11:e20-e26.
17. Strobel A., Issad T., Camoin L., et al. Aleptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 1998, 18(3):213-215.
18. Ahima R.S., Prabakaran D., Mantzoros C., et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996, 382(6588):250-252.
19. Miller K.K., Grinspoon S., Gleysteen S., et al. Preservation of neuroendocrine control of reproductive function despite severe undernutrition. JClin Endocrinol Metab 2004, 89(9):4434-4438.
20. de Roux N., Genin E., Carel J.C., et al. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci USA 2003, 100(19):10972-10976.
21. Seminara S.B., Messager S., Chatzidaki E.E., et al. The GPR54 gene as a regulator of puberty. NEngl J Med 2003, 349(17):1614-1627.
22. Jayasena C.N., Nijher G.M., Chaudhri O.B., et al. Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis. JClin Endocrinol Metab 2009, 94(11):4315-4323.
23. Welt C.K., Chan J.L., Bullen J., et al. Recombinant human leptin in women with hypothalamic amenorrhea. NEngl J Med 2004, 351(10):987-997.
24. Brambilla F., Monteleone P., Bortolotti F., et al. Persistent amenorrhoea in weight-recovered anorexics: psychological and biological aspects. Psychiatry Res 2003, 118(3):249-257.
25. Miller K.K., Lawson E.A., Mathur V., et al. Androgens in women with anorexia nervosa and normal-weight women with hypothalamic amenorrhea. JClin Endocrinol Metab 2007, 92(4):1334-1339.
26. Judd H.L., Lucas W.E., Yen S.S. Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am J Obstet Gynecol 1974, 118(6):793-798.
27. Lawson E.A., Misra M., Meenaghan E., et al. Adrenal glucocorticoid and androgen precursor dissociation in anorexia nervosa. JClin Endocrinol Metab 2009, 94(4):1367-1371.
28. Gordon C.M., Grace E., Emans S.J., et al. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial. JClin Endocrinol Metab 2002, 87(11):4935-4941.
29. Miller K.K., Meenaghan E., Lawson E.A., et al. Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study. JClin Endocrinol Metab 2011, 96(7):2081-2088.
30. Miller K.K., Wexler T.L., Zha A.M., et al. Androgen deficiency: association with increased anxiety and depression symptom severity in anorexia nervosa. JClin Psychiatry 2007, 68(6):959-965.
31. Roth J., Glick S.M., Yalow R.S., et al. Hypoglycemia: a potent stimulus to secretion of growth hormone. Science 1963, 140:987-988.
32. Stoving R.K., Veldhuis J.D., Flyvbjerg A., et al. Jointly amplified basal and pulsatile growth hormone (GH) secretion and increased process irregularity in women with anorexia nervosa: indirect evidence for disruption of feedback regulation within the GH-insulin-like growth factor I axis. JClin Endocrinol Metab 1999, 84(6):2056-2063.
33. Misra M., Miller K.K., Bjornson J., et al. Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. JClin Endocrinol Metab 2003, 88(12):5615-5623.
34. Stoving R.K., Chen J.W., Glintborg D., et al. Bioactive insulin-like growth factor (IGF) I and IGF-binding protein-1 in anorexia nervosa. JClin Endocrinol Metab 2007, 92(6):2323-2329.
35. Fazeli P.K., Lawson E.A., Prabhakaran R., et al. Effects of recombinant human growth hormone in anorexia nervosa: a randomized, placebo-controlled study. JClin Endocrinol Metab 2010, 95(11):4889-4897.
36. Hill K.K., Hill D.B., McClain M.P., et al. Serum insulin-like growth factor-I concentrations in the recovery of patients with anorexia nervosa. JAm Coll Nutr 1993, 12(4):475-478.
37. Doerr P., Fichter M., Pirke K.M., et al. Relationship between weight gain and hypothalamic pituitary adrenal function in patients with anorexia nervosa. JSteroid Biochem 1980, 13(5):529-537.
38. Gwirtsman H.E., Kaye W.H., Curtis S.R., et al. Energy intake and dietary macronutrient content in women with anorexia nervosa and volunteers. JAm Diet Assoc 1989, 89(1):54-57.
39. Schweitzer I., Szmukler G.I., Maguire K.P., et al. The dexamethasone suppression test in anorexia nervosa. The influence of weight, depression, adrenocorticotrophic hormone and dexamethasone. Br J Psychiatry 1990, 157:713-717.
40. Walsh B.T., Katz J.L., Levin J., et al. The production rate of cortisol declines during recovery from anorexia nervosa. JClin Endocrinol Metab 1981, 53(1):203-205.
41. Putignano P., Dubini A., Toja P., et al. Salivary cortisol measurement in normal-weight, obese and anorexic women: comparison with plasma cortisol. Eur J Endocrinol 2001, 145(2):165-171.
42. Grinspoon S., Thomas L., Miller K., et al. Changes in regional fat redistribution and the effects of estrogen during spontaneous weight gain in women with anorexia nervosa. Am J Clin Nutr 2001, 73(5):865-869.
43. Misra M., Prabhakaran R., Miller K.K., et al. Role of cortisol in menstrual recovery in adolescent girls with anorexia nervosa. Pediatr Res 2006, 59(4 Pt 1):598-603.
44. Lawson E.A., Donoho D., Miller K.K., et al. Hypercortisolemia is associated with severity of bone loss and depression in hypothalamic amenorrhea and anorexia nervosa. JClin Endocrinol Metab 2009, 94(12):4710-4716.
45. Grinspoon S., Gulick T., Askari H., et al. Serum leptin levels in women with anorexia nervosa. JClin Endocrinol Metab 1996, 81(11):3861-3863.
46. Hebebrand J., Blum W.F., Barth N., et al. Leptin levels in patients with anorexia nervosa are reduced in the acute stage and elevated upon short-term weight restoration. Mol Psychiatry 1997, 2(4):330-334.
47. Misra M., Miller K.K., Tsai P., et al. Elevated peptide YY levels in adolescent girls with anorexia nervosa. JClin Endocrinol Metab 2006, 91(3):1027-1033.
48. Pfluger P.T., Kampe J., Castaneda T.R., et al. Effect of human body weight changes on circulating levels of peptide YY and peptide YY3-36. JClin Endocrinol Metab 2007, 92(2):583-588.
49. Lawson E.A., Eddy K.T., Donoho D., et al. Appetite-regulating hormones cortisol and peptide YY are associated with disordered eating psychopathology, independent of body mass index. Eur J Endocrinol 2011, 164(2):253-261.
50. Misra M., Miller K.K., Kuo K., et al. Secretory dynamics of ghrelin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab 2005, 289(2):E347-E356.
51. Monteleone P., Serritella C., Martiadis V., et al. Plasma obestatin, ghrelin, and ghrelin/obestatin ratio are increased in underweight patients with anorexia nervosa but not in symptomatic patients with bulimia nervosa. JClin Endocrinol Metab 2008, 93(11):4418-4421.
52. Usdan L.S., Khaodhiar L., Apovian C.M. The endocrinopathies of anorexia nervosa. Endocr Pract 2008, 14(8):1055-1063.
53. Germain N., Galusca B., Grouselle D., et al. Ghrelin and obestatin circadian levels differentiate bingeing-purging from restrictive anorexia nervosa. JClin Endocrinol Metab 2010, 95(6):3057-3062.
54. Karczewska-Kupczewska M., Straczkowski M., Adamska A., et al. Increased suppression of serum ghrelin concentration by hyperinsulinemia in women with anorexia nervosa. Eur J Endocrinol 2010, 162(2):235-239.
55. Grinspoon S., Thomas E., Pitts S., et al. Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med 2000, 133(10):790-794.
56. Miller K.K., Lee E.E., Lawson E.A., et al. Determinants of skeletal loss and recovery in anorexia nervosa. JClin Endocrinol Metab 2006, 91(8):2931-2937.
57. Soyka L.A., Misra M., Frenchman A., et al. Abnormal bone mineral accrual in adolescent girls with anorexia nervosa. JClin Endocrinol Metab 2002, 87(9):4177-4185.
58. Misra M., Aggarwal A., Miller K.K., et al. Effects of anorexia nervosa on clinical, hematologic, biochemical, and bone density parameters in community-dwelling adolescent girls. Pediatrics 2004, 114(6):1574-1583.
59. Rigotti N.A., Neer R.M., Skates S.J., et al. The clinical course of osteoporosis in anorexia nervosa. A longitudinal study of cortical bone mass. JAMA 1991, 265(9):1133-1138.
60. Lawson E.A., Miller K.K., Bredella M.A., et al. Hormone predictors of abnormal bone microarchitecture in women with anorexia nervosa. Bone 2010, 46(2):458-463.
61. Faje A.T., Karim L., Taylor A., et al. Adolescent girls with anorexia nervosa have impaired cortical and trabecular microarchitecture and lower estimated bone strength at the distal radius. JClin Endocrinol Metab 2013, 98(5):1923-1929.
62. Bredella M.A., Misra M., Miller K.K., et al. Distal radius in adolescent girls with anorexia nervosa: trabecular structure analysis with high-resolution flat-panel volume CT. Radiology 2008, 249(3):938-946.
63. Walsh C.J., Phan C.M., Misra M., et al. Women with anorexia nervosa: finite element and trabecular structure analysis by using flat-panel volume CT. Radiology 2010, 257(1):167-174.
64. Herzog W., Minne H., Deter C., et al. Outcome of bone mineral density in anorexia nervosa patients 11.7 years after first admission. JBone Miner Res 1993, 8(5):597-605.
65. Grinspoon S., Baum H., Lee K., et al. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. JClin Endocrinol Metab 1996, 81(11):3864-3870.
66. Misra M., Soyka L.A., Miller K.K., et al. Serum osteoprotegerin in adolescent girls with anorexia nervosa. JClin Endocrinol Metab 2003, 88(8):3816-3822.
67. Grinspoon S., Miller K., Coyle C., et al. Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea. JClin Endocrinol Metab 1999, 84(6):2049-2055.
68. Bredella M.A., Fazeli P.K., Miller K.K., et al. Increased bone marrow fat in anorexia nervosa. JClin Endocrinol Metab 2009, 94(6):2129-2136.
69. Hadigan C.M., Anderson E.J., Miller K.K., et al. Assessment of macronutrient and micronutrient intake in women with anorexia nervosa. Int J Eat Disord 2000, 28(3):284-292.
70. Misra M., Tsai P., Anderson E.J., et al. Nutrient intake in community-dwelling adolescent girls with anorexia nervosa and in healthy adolescents. Am J Clin Nutr 2006, 84(4):698-706.
71. Klibanski A., Biller B.M., Schoenfeld D.A., et al. The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. JClin Endocrinol Metab 1995, 80(3):898-904.
72. Grinspoon S., Thomas L., Miller K., et al. Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. JClin Endocrinol Metab 2002, 87(6):2883-2891.
73. Misra M., Katzman D., Miller K.K., et al. Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa. JBone Miner Res 2011, 26(10):2430-2438.
74. Miller K.K., Grieco K.A., Klibanski A. Testosterone administration in women with anorexia nervosa. JClin Endocrinol Metab 2005, 90(3):1428-1433.
75. Divasta A.D., Feldman H.A., Giancaterino C., et al. The effect of gonadal and adrenal steroid therapy on skeletal health in adolescents and young women with anorexia nervosa. Metabolism 2012, 61(7):1010-1020.
76. Bloch M., Ish-Shalom S., Greenman Y., et al. Dehydroepiandrosterone treatment effects on weight, bone density, bone metabolism and mood in women suffering from anorexia nervosa-a pilot study. Psychiatry Res 2012, 200(2-3):544-549.
77. Misra M., Miller K.K., Almazan C., et al. Alterations in cortisol secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. JClin Endocrinol Metab 2004, 89(10):4972-4980.
78. Utz A.L., Lawson E.A., Misra M., et al. Peptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosa. Bone 2008, 43(1):135-139.
79. Golden N.H., Iglesias E.A., Jacobson M.S., et al. Alendronate for the treatment of osteopenia in anorexia nervosa: a randomized, double-blind, placebo-controlled trial. JClin Endocrinol Metab 2005, 90(6):3179-3185.
80. Waugh E.J., Woodside D.B., Beaton D.E., et al. Effects of exercise on bone mass in young women with anorexia nervosa. Med Sci Sports Exerc 2011, 43(5):755-763.